The reduction in price target by Wells Fargo, a major financial institution, could lead to a negative short-term impact on CVS Health's stock price. Investors often view such adjustments as a signal of the analyst's view on the stock's future performance, potentially leading to decreased investor confidence and a drop in stock price.